---
title: "Data reinforcing efficacy and safety of gadopiclenol in contrast-enhanced MRI published in Radiology"
date: "2023-07-27T12:19:45.000Z"
publishedDate: "27 juillet 2023"
summary: "Bracco Imaging has announced the publication of the PROMISE trial in Radiology. The PROMISE study was a prospective, multinational, crossover (within-patient), double-blind comparison of the safety and efficacy of 0.05 mmol/kg gadopiclenol (Vueway) with 0.1 mmol/kg gadobutrol (Gadavist) in adult patients referred for contrast-enhanced magnetic resonance imaging (MRI) of head and neck, thorax (including breast), abdomen [&#8230;] The post Data reinforcing efficacy and safety of gadopiclenol in contrast-enhanced MRI published in Radiology appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/data-reinforcing-efficacy-and-safety-of-gadopiclenol-in-contrast-enhanced-mri-published-in-radiology/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-07-27-data-reinforcing-efficacy-and-safety-of-gadopiclenol-in-contrast-enhanced-mri-published-in-radiology"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/07/bracco.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/data-reinforcing-efficacy-and-safety-of-gadopiclenol-in-contrast-enhanced-mri-published-in-radiology/"
---

![Data reinforcing efficacy and safety of gadopiclenol in contrast-enhanced MRI published in Radiology](https://interventionalnews.com/wp-content/uploads/sites/13/2023/07/bracco.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/data-reinforcing-efficacy-and-safety-of-gadopiclenol-in-contrast-enhanced-mri-published-in-radiology/*

## L’essentiel

Bracco Imaging has announced the publication of the PROMISE trial in Radiology. The PROMISE study was a prospective, multinational, crossover (within-patient), double-blind comparison of the safety and efficacy of 0.05 mmol/kg gadopiclenol (Vueway) with 0.1 mmol/kg gadobutrol (Gadavist) in adult patients referred for contrast-enhanced magnetic resonance imaging (MRI) of head and neck, thorax (including breast), abdomen [&#8230;] The post Data reinforcing efficacy and safety of gadopiclenol in contrast-enhanced MRI published in Radiology appeared first on Interventional News .

## Lien source

https://interventionalnews.com/data-reinforcing-efficacy-and-safety-of-gadopiclenol-in-contrast-enhanced-mri-published-in-radiology/
